- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05616806
Long COVID-19 Intervention Using Digital Health & Technology (LIGHT)
Project LIGHT - Long COVID-19 Intervention Using Digital Health & Technology
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Rhode Island
-
Providence, Rhode Island, United States, 02903
- Rhode Island Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Must be over 18 years of age
- Must speak English proficiently
- Must own a text-enabled device
- Diagnosis (self-reported) of COVID-19
- Diagnosis (self-reported) of Long-COVID symptom(s)
- Must be able to provide written, informed consent
Exclusion Criteria:
- Not fluent in English
- Limited mental capacity or inability to provide informed written consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: distress tolerance skills training
technology delivered distress tolerance skills training
|
Two delivery modes: computer and text message. The intervention provides introductory strategies for managing physical and emotional distress associated with Long COVID through a computer-delivered session followed by 4-weeks of theoretically-informed text messages intended to promote distress tolerance (DT). Computer - the initial intervention will be delivered online via the Qualtrics survey tool following informed consent. The intervention provides strategies to better tolerate emotional and physical discomfort to persist with behavioral goals. Text Message - The text message intervention will be delivered using Marigold Health (a HIPAA compliant platform for secure text messaging). Participants will receive daily text messages that focus on emphasizing adaptive strategies for tolerating physical and emotional discomfort in order to work toward behavioral goals. The text messages will be personalized and offer skills training (reminders of previously learned DT skills).
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Client Satisfaction Score (CSQ-8)
Time Frame: 4 weeks
|
Measure satisfaction scores after 4 weeks of using the intervention for this group of participants with Long COVID as measured by the client satisfaction questionnaire.
Total scores range from 8 to 32, with the higher number indicating greater satisfaction.
|
4 weeks
|
System Usability Score (SUS)
Time Frame: 4 weeks
|
Measure usability after 4 weeks for this group of participants with Long COVID as measured by the 10 item system usability scale.
In the SUS instrument, even and odd questions are scored differently.
Odd questions are scored 0-4 based on the 1-5 selection, where a selection of 1 equals 0 points, a selection of 2 equals 1 point, and so on.
Even questions are scored 4-0 on the 1-5 selection where a selection of 1 equals 4 points, a selection of 2 equals 3 points, and so on.
Scores for all ten questions are added up for a total score between 0-40 points.
This total is multiplied by 2.5 to generate a SUS score between 0-100 points.
Based on research, a SUS score above a 68 would be considered above average and anything below 68 is below average.
|
4 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Kirsten Langdon, PhD, Brown University
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2022003396
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Long COVID
-
Miami VA Healthcare SystemNot yet recruiting
-
Endourage, LLCRecruitingLong COVID | Long Covid19 | Post-Acute COVID-19 | Long Haul COVID | Long-Haul COVID-19 | Post-Acute COVID-19 SyndromeUnited States
-
University Hospital, AkershusRecruiting
-
Anxiety Relief CenterCompleted
-
Rutger LalieuDaVinci KliniekRecruitingLong COVID | Long Covid19 | Long COVID-19 Syndrome | Long Covid 19Netherlands
-
Lundquist Institute for Biomedical Innovation at...RecruitingLong Haul COVID or Post Acute Sequella of COVID - PASC (U09.9)United States
-
National Institutes of Health Clinical Center (CC)CompletedAcute and Long Term Effects of COVID-19 on Systemic Inflammation | Acute and Long Term Effects of COVID-19 on Lung Function | Acute and Long Term Effects of COVID-19 on Cardiac Function | Acute and Long Term Effects of COVID-19 on Kidney Function | Acute and Long Term Effects of COVID-19...United States
-
Lawson Health Research InstituteWestern UniversityNot yet recruitingFatigue | Post-COVID-19 Syndrome | Long Covid19 | Post-COVID Syndrome | Long-COVID
-
University Hospital, AngersNot yet recruiting
-
Kanecia Obie ZimmermanEnrolling by invitationLong COVID | Long Covid-19 | Long Coronavirus Disease 2019 (Covid19)United States
Clinical Trials on iENDURE
-
Rhode Island HospitalNational Institute on Drug Abuse (NIDA)CompletedOpioid Use Disorder | Treatment AdherenceUnited States